https://news.medxy.ai/zh/fgf18-fgfr3-leukemia/Medxy AIzh2026-10-09T04:35:03-07:00瞄准 FGF18-FGFR3 轴：急性髓系白血病治疗的新前沿 https://news.medxy.ai/ja/fgf18-fgfr3-leukemia-treatment/Medxy AIja2026-10-09T04:34:48-07:00FGF18-FGFR3軸を標的とした急性骨髄性白血病治療の新たな展開 https://news.medxy.ai/vi/fgf18-fgfr3-target/Medxy AIvi2026-10-09T04:34:29-07:00Nhắm trúng trục FGF18-FGFR3: Hướng đi mới trong điều trị bệnh bạch cầu tủy cấp https://news.medxy.ai/targeting-the-fgf18-fgfr3-axis-a-new-frontier-in-acute-myeloid-leukemia-therapy/Medxy AIen2026-10-09T04:34:10-07:00Targeting the FGF18-FGFR3 Axis: A New Frontier in Acute Myeloid Leukemia Therapy https://news.medxy.ai/zh/aav-factor-viii-activation-2/Medxy AIzh2026-10-09T04:33:32-07:00一期法揭示AAV来源凝血因子VIII凝血酶激活增强：对血友病A基因治疗的启示 https://news.medxy.ai/ja/aav-factor-viii-activation/Medxy AIja2026-10-09T04:33:15-07:00AAV由来第VIII因子のトロンビン活性化亢進を一段階凝固検査で検出：血友病A遺伝子治療への示唆 https://news.medxy.ai/vi/aav-fviii-thrombin-activation/Medxy AIvi2026-10-09T04:32:57-07:00Xét nghiệm một giai đoạn cho thấy AAV-FVIII hoạt hóa thrombin mạnh hơn: Hàm ý đối với liệu pháp gen hemophilia A https://news.medxy.ai/one-stage-assay-reveals-enhanced-thrombin-activation-by-aav-derived-factor-viii-implications-for-hemophilia-a-gene-therapy/Medxy AIen2026-10-09T04:32:39-07:00One-stage Assay Reveals Enhanced Thrombin Activation by AAV-Derived Factor VIII: Implications for Hemophilia A Gene Therapy https://news.medxy.ai/zh/antifibrotic-dose-adjustment/Medxy AIzh2026-10-09T04:31:59-07:00抗纤维化药物剂量调整对特发性肺纤维化结局的影响：来自真实世界数据的启示 https://news.medxy.ai/ja/dose-adjustment-antifibrotics/Medxy AIja2026-10-09T04:31:42-07:00抗線維化薬の用量調整は特発性肺線維症の転帰にどう影響するのか：リアルワールドデータからの知見 https://news.medxy.ai/impact-of-antifibrotic-dose-modifications-on-idiopathic-pulmonary-fibrosis-outcomes-insights-from-real-world-data/Medxy AIen2026-10-09T04:31:06-07:00Impact of Antifibrotic Dose Modifications on Idiopathic Pulmonary Fibrosis Outcomes: Insights from Real-World Data https://news.medxy.ai/zh/cystic-fibrosis-aspergillosis-treatment/Medxy AIzh2026-10-09T04:30:30-07:00囊性纤维化合并过敏性支气管肺曲霉病：口服糖皮质激素与抗真菌治疗的真实世界疗效对比 https://news.medxy.ai/ja/cf-abpa-treatment-comparison/Medxy AIja2026-10-09T04:30:12-07:00嚢胞性線維症合併ABPAに対する経口コルチコステロイドと抗真菌薬の実臨床効果の比較 https://news.medxy.ai/vi/oral-steroids-vs-antifungals/Medxy AIvi2026-10-09T04:29:54-07:00Corticosteroid đường uống hay thuốc kháng nấm: điều gì hiệu quả hơn trong ABPA ở bệnh nhân xơ nang? https://news.medxy.ai/real-world-effectiveness-of-oral-corticosteroids-versus-antifungals-in-allergic-bronchopulmonary-aspergillosis-among-cystic-fibrosis-patients/Medxy AIen2026-10-09T04:29:37-07:00Real-World Effectiveness of Oral Corticosteroids Versus Antifungals in Allergic Bronchopulmonary Aspergillosis Among Cystic Fibrosis Patients https://news.medxy.ai/zh/wbc-sepsis-antibiotics/Medxy AIzh2026-10-09T04:29:00-07:00白细胞计数能否预测脓毒症抗生素疗效？来自头孢吡肟与哌拉西林-他唑巴坦比较研究的启示 https://news.medxy.ai/ja/white-blood-cell-predictor/Medxy AIja2026-10-09T04:28:44-07:00敗血症における抗菌薬有効性の予測因子としての白血球数――セフェピムとピペラシリン・タゾバクタム比較研究からの示唆 https://news.medxy.ai/vi/white-blood-cells-antibiotics/Medxy AIvi2026-10-09T04:28:25-07:00Số lượng bạch cầu có dự đoán hiệu quả kháng sinh trong nhiễm trùng huyết? Bằng chứng từ các nghiên cứu so sánh cefepime và piperacillin-tazobactam https://news.medxy.ai/white-blood-cell-count-as-a-predictor-of-antibiotic-efficacy-in-sepsis-insights-from-comparative-studies-of-cefepime-and-piperacillin-tazobactam/Medxy AIen2026-10-09T04:28:07-07:00White Blood Cell Count as a Predictor of Antibiotic Efficacy in Sepsis: Insights from Comparative Studies of Cefepime and Piperacillin-Tazobactam https://news.medxy.ai/zh/occupational-dust-smoke-risks/Medxy AIzh2026-10-09T04:27:30-07:00职业性粉尘与烟雾暴露会增加吸烟者呼吸与心血管并发症风险 https://news.medxy.ai/ja/smoking-exposure-risk/Medxy AIja2026-10-09T04:27:14-07:00喫煙者における粉じん・ヒューム曝露、呼吸器および心血管合併症のリスクを上昇 https://news.medxy.ai/vi/82111-2/Medxy AIvi2026-10-09T04:26:55-07:00Việc tiếp xúc với bụi và khói bụi trong môi trường làm việc làm tăng nguy cơ gặp các biến chứng về hô hấp và tim mạch ở người hút thuốc https://news.medxy.ai/occupational-dust-and-fume-exposure-elevates-risk-of-respiratory-and-cardiovascular-complications-in-smokers/Medxy AIen2026-10-09T04:26:36-07:00Occupational Dust and Fume Exposure Elevates Risk of Respiratory and Cardiovascular Complications in Smokers https://news.medxy.ai/zh/abicipar-octa-treatment/Medxy AIzh2026-10-09T04:25:56-07:00基于纵向OCTA评估阿柏西普联合低能量光动力治疗在脉络膜息肉样血管病变中的疗效 https://news.medxy.ai/ja/aflibercept-pdt-pcv/Medxy AIja2026-10-09T04:25:39-07:00PCVにおけるアフリベルセプトと低照射量PDTの併用効果を検証：長期OCTA解析からみた所見 https://news.medxy.ai/evaluating-aflibercept-with-reduced-fluence-photodynamic-therapy-in-polypoidal-choroidal-vasculopathy-insights-from-longitudinal-oct-angiography/Medxy AIen2026-10-09T04:25:02-07:00Evaluating Aflibercept With Reduced-Fluence Photodynamic Therapy in Polypoidal Choroidal Vasculopathy: Insights from Longitudinal OCT Angiography https://news.medxy.ai/zh/wide-angle-oct-tumor-2/Medxy AIzh2026-10-09T04:24:26-07:00超广角扫频源OCT在脉络膜肿瘤评估中的应用：与超声、SD-OCT及MRI的比较分析 https://news.medxy.ai/ja/wide-angle-oct-tumor/Medxy AIja2026-10-09T04:24:09-07:00超広角掃引光源OCTで脈絡膜腫瘍評価を高精度化：超音波検査、SD-OCT、MRIとの比較解析 https://news.medxy.ai/vi/wide-field-oct-uveal-tumor/Medxy AIvi2026-10-09T04:23:50-07:00Nâng cao đánh giá u màng mạch nho bằng OCT nguồn quét diện trường siêu rộng: phân tích so sánh với siêu âm, SD-OCT và MRI https://news.medxy.ai/enhancing-choroidal-tumor-assessment-with-ultra-widefield-swept-source-oct-a-comparative-analysis-with-ultrasonography-sd-oct-and-mri/Medxy AIen2026-10-09T04:23:32-07:00Enhancing Choroidal Tumor Assessment with Ultra-Widefield Swept-Source OCT: A Comparative Analysis with Ultrasonography, SD-OCT, and MRI https://news.medxy.ai/zh/functional-rhinoplasty/Medxy AIzh2026-10-09T04:22:52-07:00功能性鼻整形术：从症状改善到长期生活质量提升 https://news.medxy.ai/ja/functional-rhinoplasty-qol/Medxy AIja2026-10-09T04:22:37-07:00機能的鼻形成術の疾患特異的改善が長期QOLに結び付く仕組み https://news.medxy.ai/vi/functional-rhinoplasty-benefits/Medxy AIvi2026-10-09T04:22:20-07:00Phẫu thuật tạo hình mũi chức năng: Liên hệ giữa cải thiện triệu chứng và chất lượng cuộc sống lâu dài https://news.medxy.ai/linking-disease-specific-gains-to-long-term-quality-of-life-in-functional-rhinoplasty/Medxy AIen2026-10-09T04:22:04-07:00Linking Disease-Specific Gains to Long-Term Quality of Life in Functional Rhinoplasty https://news.medxy.ai/zh/tracheal-surgery-comparison/Medxy AIzh2026-10-09T04:21:26-07:00滑行气管成形术与端端吻合术的力学差异：离体猪气管模型分析 https://news.medxy.ai/ja/tracheoplasty-mechanics/Medxy AIja2026-10-09T04:21:08-07:00スライド気管形成術と端々吻合の力学的差異：ex vivo豚気管モデルによる解析 https://news.medxy.ai/vi/tracheoplasty-analysis/Medxy AIvi2026-10-09T04:20:52-07:00Phân tích cơ học giữa slide tracheoplasty và nối tận – tận: nghiên cứu trên mô hình khí quản lợn ex vivo https://news.medxy.ai/mechanical-insights-into-slide-tracheoplasty-versus-end-to-end-anastomosis-an-ex-vivo-porcine-model-analysis/Medxy AIen2026-10-09T04:20:34-07:00Mechanical Insights into Slide Tracheoplasty Versus End-to-End Anastomosis: An Ex Vivo Porcine Model Analysis https://news.medxy.ai/zh/thyroid-surgery-parathyroid-preservation/Medxy AIzh2026-10-09T04:19:58-07:00全甲状腺切除中甲状旁腺保留的新视角：近红外自发荧光的长期随机试验结果 https://news.medxy.ai/ja/thyroid-surgery-fluorescence/Medxy AIja2026-10-09T04:19:41-07:00甲状腺全摘術における副甲状腺温存のための近赤外自家蛍光評価：前向き無作為化試験の長期成績 https://news.medxy.ai/vi/82065-2/Medxy AIvi2026-10-09T04:19:21-07:00Những quan điểm mới về việc bảo tồn tuyến cận giáp trong phẫu thuật cắt toàn bộ tuyến giáp https://news.medxy.ai/evaluating-near-infrared-autofluorescence-for-parathyroid-preservation-in-total-thyroidectomy-long-term-outcomes-from-a-prospective-randomized-trial/Medxy AIen2026-10-09T04:19:04-07:00Evaluating Near-Infrared Autofluorescence for Parathyroid Preservation in Total Thyroidectomy: Long-Term Outcomes from a Prospective Randomized Trial https://news.medxy.ai/zh/hernia-recurrence-age/Medxy AIzh2026-10-09T04:18:28-07:00原发性腹壁疝修补术后复发风险受年龄影响：对临床实践的启示 https://news.medxy.ai/ja/hernia-recurrence-age-2/Medxy AIja2026-10-09T04:18:11-07:00一次腹壁ヘルニア修復後の再発リスクは年齢で変わる：臨床実践への示唆 https://news.medxy.ai/vi/hernia-repair-risks/Medxy AIvi2026-10-09T04:17:53-07:00Nguy cơ tái phát sau sửa chữa thoát vị thành bụng nguyên phát thay đổi theo tuổi: ý nghĩa đối với thực hành lâm sàng https://news.medxy.ai/age-dependent-recurrence-risk-after-primary-ventral-hernia-repair-implications-for-clinical-practice/Medxy AIen2026-10-09T04:17:36-07:00Age-Dependent Recurrence Risk After Primary Ventral Hernia Repair: Implications for Clinical Practice https://news.medxy.ai/zh/wilms-tumor-prognosis/Medxy AIzh2026-10-09T04:17:01-07:00早期有利组织学型 Wilms 肿瘤中的年龄、肿瘤大小与体重：基于 COG 数据重新评估预后指标 https://news.medxy.ai/ja/wilms-tumor-prognosis-2/Medxy AIja2026-10-09T04:16:44-07:00早期良好組織型Wilms腫瘍における年齢・腫瘍サイズ・体重の意義：COGデータで予後指標を再評価する https://news.medxy.ai/vi/wilms-tumor-factors/Medxy AIvi2026-10-09T04:16:24-07:00Tuổi, kích thước khối u và trọng lượng trong u Wilms mô học thuận lợi giai đoạn sớm: Xem xét lại các chỉ dấu tiên lượng từ dữ liệu COG https://news.medxy.ai/age-tumor-size-and-weight-in-early-stage-favorable-histology-wilms-tumor-reevaluating-prognostic-indicators-with-cog-data/Medxy AIen2026-10-09T04:16:07-07:00Age, Tumor Size, and Weight in Early-Stage Favorable Histology Wilms Tumor: Reevaluating Prognostic Indicators with COG Data https://news.medxy.ai/zh/gastroduodenal-reconstruction/Medxy AIzh2026-10-09T03:33:48-07:00胰十二指肠切除术后胃空肠吻合方式如何选择：侧侧与端侧重建对延迟性胃排空的影响 https://news.medxy.ai/ja/gastrectomy-anastomosis-comparison/Medxy AIja2026-10-09T03:33:31-07:00膵頭十二指腸切除後の胃空腸吻合法を検証：側側吻合と端側吻合の比較と遅延胃排出への影響 https://news.medxy.ai/vi/pancreaticojejunostomy-comparison/Medxy AIvi2026-10-09T03:33:11-07:00So sánh các kỹ thuật nối vị – hỗng tràng trong phẫu thuật cắt tá tụy: nối bên – bên hay tận – bên và ảnh hưởng lên chậm làm rỗng dạ dày https://news.medxy.ai/evaluating-gastrojejunostomy-techniques-in-pancreatoduodenectomy-side-to-side-vs-end-to-side-approaches-and-impact-on-delayed-gastric-emptying/Medxy AIen2026-10-09T03:32:45-07:00Evaluating Gastrojejunostomy Techniques in Pancreatoduodenectomy: Side-to-Side vs End-to-Side Approaches and Impact on Delayed Gastric Emptying https://news.medxy.ai/zh/latina-fibroids-insights/Medxy AIzh2026-10-09T03:32:08-07:00拉丁裔女性子宫肌瘤：来自 ELLA 研究的环境、平滑肌瘤、拉丁裔女性与脂肪性洞见 https://news.medxy.ai/ja/latina-leiomyomas/Medxy AIja2026-10-09T03:31:51-07:00Latina 女性の子宮筋腫：Environment, Leiomyomas, Latinas, and Adiposity Study からの知見 https://news.medxy.ai/vi/uterine-fibroids-latinas/Medxy AIvi2026-10-09T03:31:30-07:00U xơ tử cung ở phụ nữ Latina: những phát hiện từ nghiên cứu Environment, Leiomyomas, Latinas, and Adiposity https://news.medxy.ai/uterine-fibroids-in-latinas-insights-from-the-environment-leiomyomas-latinas-and-adiposity-study/Medxy AIen2026-10-09T03:31:09-07:00Uterine Fibroids in Latinas: Insights from the Environment, Leiomyomas, Latinas, and Adiposity Study https://news.medxy.ai/zh/82025-2/Medxy AIzh2026-10-09T03:30:19-07:00多发性硬化症中上颈髓萎缩的解析：区分衰老与疾病的影响 https://news.medxy.ai/ja/82023-2/Medxy AIja2026-10-09T03:30:01-07:00多発性硬化症における上位頸髄萎縮の解明：加齢と疾患の影響の切り分け https://news.medxy.ai/vi/82022-2/Medxy AIvi2026-10-09T03:29:43-07:00Làm sáng tỏ tình trạng teo tủy sống cổ đoạn cao trong bệnh đa xơ cứng: Phân tách ảnh hưởng của lão hóa và bệnh lý https://news.medxy.ai/decoding-upper-cervical-cord-atrophy-in-multiple-sclerosis-separating-aging-from-disease-effects/Medxy AIen2026-10-09T03:29:24-07:00Decoding Upper Cervical Cord Atrophy in Multiple Sclerosis: Separating Aging from Disease Effects https://news.medxy.ai/zh/rapid-genome-sequencing-pediatrics/Medxy AIzh2026-10-09T03:28:42-07:00快速全基因组测序重塑儿科神经科住院诊疗：诊断与管理价值显著提升 https://news.medxy.ai/ja/82013-2/Medxy AIja2026-10-09T03:28:22-07:00小児神経診療の変革：入院患者の診断と管理における迅速全ゲノムシーケンシングの影響 https://news.medxy.ai/vi/pediatric-neurocare-genomics/Medxy AIvi2026-10-09T03:28:02-07:00Cách mạng hóa chăm sóc thần kinh nhi khoa: Tác động của giải trình tự toàn bộ bộ gen nhanh trong chẩn đoán và xử trí nội trú https://news.medxy.ai/transforming-pediatric-neurology-care-the-impact-of-rapid-whole-genome-sequencing-in-inpatient-diagnosis-and-management/Medxy AIen2026-10-09T03:27:43-07:00Transforming Pediatric Neurology Care: The Impact of Rapid Whole-Genome Sequencing in Inpatient Diagnosis and Management https://news.medxy.ai/zh/blood-biomarkers-cognitive-impairment/Medxy AIzh2026-10-09T03:27:03-07:00血液生物标志物提前披露：提升认知障碍诊断把握并优化临床管理的新证据 https://news.medxy.ai/ja/blood-biomarkers-dementia/Medxy AIja2026-10-09T03:26:41-07:00血液バイオマーカーの早期開示が認知症診断と臨床判断をどう変えるか：最新ランダム化試験のレビュー https://news.medxy.ai/vi/biomarker-detection/Medxy AIvi2026-10-09T03:26:21-07:00Công bố sớm dấu ấn sinh học trong máu giúp tăng độ chắc chắn chẩn đoán và hỗ trợ quản lý lâm sàng trong rối loạn nhận thức: Tổng quan về một thử nghiệm lâm sàng ngẫu nhiên gần đây https://news.medxy.ai/earlier-disclosure-of-blood-based-biomarkers-enhances-diagnostic-certainty-and-clinical-management-in-cognitive-disorders-a-review-of-a-recent-randomized-clinical-trial/Medxy AIen2026-10-09T03:26:01-07:00Earlier Disclosure of Blood-Based Biomarkers Enhances Diagnostic Certainty and Clinical Management in Cognitive Disorders: A Review of a Recent Randomized Clinical Trial https://news.medxy.ai/zh/diabetes-diagnosis-gap/Medxy AIzh2026-10-09T03:25:17-07:00实验室确诊糖尿病为何仍有“诊疗断层”？全国队列研究带来新启示 https://news.medxy.ai/ja/81999-2/Medxy AIja2026-10-09T03:25:02-07:00検査で糖尿病と確定診断されても、なお「診療の断絶」が生じるのはなぜか？ https://news.medxy.ai/vi/diabetes-care-gap/Medxy AIvi2026-10-09T03:24:44-07:00Thu hẹp khoảng cách giữa chẩn đoán và điều trị ở bệnh nhân đái tháo đường được xác nhận bằng xét nghiệm: Góc nhìn từ một nghiên cứu đoàn hệ toàn quốc https://news.medxy.ai/bridging-the-diagnostic-and-treatment-divide-in-laboratory-confirmed-diabetes-insights-from-a-national-cohort-study/Medxy AIen2026-10-09T03:24:26-07:00Bridging the Diagnostic and Treatment Divide in Laboratory-Confirmed Diabetes: Insights from a National Cohort Study https://news.medxy.ai/zh/eye-proton-therapy-effects/Medxy AIzh2026-10-09T03:16:39-07:00眼部质子治疗对葡萄膜黑色素瘤患者角膜基底下神经丛的长期影响 https://news.medxy.ai/ja/81977-2/Medxy AIja2026-10-09T03:16:21-07:00ぶどう膜悪性黒色腫患者における眼部陽子線治療が角膜上皮下神経叢に及ぼす長期的な影響 https://news.medxy.ai/vi/long-term-proton-therapy-impact/Medxy AIvi2026-10-09T03:16:00-07:00Tác động dài hạn của xạ trị proton mắt lên đám rối thần kinh dưới biểu mô giác mạc ở bệnh nhân u hắc tố màng bồ đào https://news.medxy.ai/longitudinal-effects-of-ocular-proton-therapy-on-the-corneal-subbasal-nerve-plexus-in-uveal-melanoma-patients/Medxy AIen2026-10-09T03:15:40-07:00Longitudinal Effects of Ocular Proton Therapy on the Corneal Subbasal Nerve Plexus in Uveal Melanoma Patients https://news.medxy.ai/zh/car-t-therapy-effects/Medxy AIzh2026-10-09T03:14:57-07:00克隆性造血与治疗前中性粒细胞减少症对血液系统恶性肿瘤CAR-T疗效和毒性的影响 https://news.medxy.ai/ja/car-t-therapy-blood-cancer/Medxy AIja2026-10-09T03:14:40-07:00血液悪性腫瘍におけるCAR-T細胞療法の成績に及ぼすクローン性造血と治療前好中球減少の影響 https://news.medxy.ai/vi/car-t-treatment-effects/Medxy AIvi2026-10-09T03:14:21-07:00Tạo máu dòng vô tính và giảm bạch cầu trung tính trước điều trị ảnh hưởng thế nào đến kết quả CAR-T ở các ác tính huyết học? https://news.medxy.ai/impact-of-clonal-hematopoiesis-and-pre-treatment-neutropenia-on-car-t-cell-therapy-outcomes-in-hematological-malignancies/Medxy AIen2026-10-09T03:14:03-07:00Impact of Clonal Hematopoiesis and Pre-treatment Neutropenia on CAR-T Cell Therapy Outcomes in Hematological Malignancies https://news.medxy.ai/zh/bcell-lymphoma-treatment/Medxy AIzh2026-10-09T03:13:27-07:00大B细胞淋巴瘤一线治疗的复杂性如何破局：迈向统一的试验设计 https://news.medxy.ai/ja/b-cell-lymphoma-treatment/Medxy AIja2026-10-09T03:13:07-07:00大B細胞リンパ腫における治療の複雑性を読み解く：一次治療試験デザインの標準化に向けて https://news.medxy.ai/vi/large-b-cell-lymphoma/Medxy AIvi2026-10-09T03:12:43-07:00U lympho tế bào B lớn: Giảm độ phức tạp điều trị và hướng tới thiết kế thử nghiệm hàng đầu tiên hài hòa https://news.medxy.ai/navigating-the-therapeutic-complexity-in-large-b-cell-lymphoma-toward-harmonized-first-line-trial-designs/Medxy AIen2026-10-09T03:12:23-07:00Navigating the Therapeutic Complexity in Large B-Cell Lymphoma: Toward Harmonized First-Line Trial Designs https://news.medxy.ai/zh/elder-care-challenges/Medxy AIzh2026-10-09T02:42:23-07:00居家护理员照护老年人：工作挑战与福祉提升之道 https://news.medxy.ai/ja/overcoming-home-care-challenges/Medxy AIja2026-10-09T02:42:05-07:00在宅医療補助者の職場課題を乗り越え、ウェルビーイングを高めるために https://news.medxy.ai/vi/workplace-healthcare-caregivers/Medxy AIvi2026-10-09T02:41:46-07:00Vượt qua thách thức nơi làm việc và nâng cao sức khỏe cho nhân viên trợ giúp chăm sóc sức khỏe tại nhà khi chăm sóc người cao tuổi https://news.medxy.ai/navigating-workplace-challenges-and-enhancing-well-being-among-home-health-aides-caring-for-older-adults/Medxy AIen2026-10-09T02:41:23-07:00Navigating Workplace Challenges and Enhancing Well-being Among Home Health Aides Caring for Older Adults https://news.medxy.ai/zh/equitable-home-hospital/Medxy AIzh2026-10-09T02:40:44-07:00推动居家医院项目的公平发展：关于可及性、入组与价值的领导层见解 https://news.medxy.ai/ja/hospital-at-home-equity/Medxy AIja2026-10-09T02:40:25-07:00Hospital at Homeプログラムにおける公平性の前進：アクセス、登録、価値をめぐるリーダーの示唆 https://news.medxy.ai/vi/hospital-at-home-equity-2/Medxy AIvi2026-10-09T02:40:02-07:00Thúc đẩy công bằng trong chương trình Hospital at Home: Góc nhìn lãnh đạo về khả năng tiếp cận, tuyển chọn và giá trị https://news.medxy.ai/advancing-equity-in-hospital-at-home-programs-leadership-insights-on-access-enrollment-and-value/Medxy AIen2026-10-09T02:39:39-07:00Advancing Equity in Hospital at Home Programs: Leadership Insights on Access, Enrollment, and Value https://news.medxy.ai/zh/prostate-cancer-screening-benefits/Medxy AIzh2026-10-09T02:39:00-07:00让前列腺癌筛查更贴近获益：来自VA与Medicare实践的启示 https://news.medxy.ai/ja/prostate-cancer-screening-3/Medxy AIja2026-10-09T02:38:38-07:00患者利益に沿った前立腺がんスクリーニングへ：VAとMedicareの実践から見える示唆 https://news.medxy.ai/vi/prostate-cancer-screening-2/Medxy AIvi2026-10-09T02:38:15-07:00Tầm soát ung thư tuyến tiền liệt phù hợp hơn với lợi ích bệnh nhân: Góc nhìn từ thực hành VA và Medicare https://news.medxy.ai/aligning-prostate-cancer-screening-with-patient-benefit-insights-from-va-and-medicare-practices/Medxy AIen2026-10-09T02:37:53-07:00Aligning Prostate Cancer Screening with Patient Benefit: Insights from VA and Medicare Practices https://news.medxy.ai/ja/fasting-duration-effects/Medxy AIja2026-10-09T02:37:12-07:00採血前絶食の長さは検査結果にどこまで影響するか https://news.medxy.ai/vi/fasting-time-differences-tests/Medxy AIvi2026-10-09T02:36:50-07:00Thời gian nhịn ăn và sự khác biệt giữa các xét nghiệm xét nghiệm thường quy https://news.medxy.ai/fasting-duration-and-differences-across-routine-laboratory-tests/Medxy AIen2026-10-09T02:36:30-07:00Fasting Duration and Differences Across Routine Laboratory Tests https://news.medxy.ai/ja/remote-cbt-chest-pain/Medxy AIja2026-10-08T09:35:41-07:00救急外来で低リスク胸痛を呈した不安患者への遠隔CBT：PACER無作為化臨床試験からの知見 https://news.medxy.ai/vi/remote-cbt-anxiety/Medxy AIvi2026-10-08T09:35:19-07:00CBT qua y tế từ xa cho lo âu ở bệnh nhân đau ngực nguy cơ thấp tại khoa cấp cứu: Góc nhìn từ thử nghiệm lâm sàng ngẫu nhiên PACER https://news.medxy.ai/telehealth-cognitive-behavioral-therapy-for-anxiety-in-emergency-department-patients-with-low-risk-chest-pain-insights-from-the-pacer-randomized-clinical-trial/Medxy AIen2026-10-08T09:34:57-07:00Telehealth Cognitive Behavioral Therapy for Anxiety in Emergency Department Patients with Low-Risk Chest Pain: Insights from the PACER Randomized Clinical Trial https://news.medxy.ai/zh/education-supervision-recovery/Medxy AIzh2026-10-08T09:34:12-07:00教育加监督运动，助力前交叉韧带重建后年轻成人恢复：一项随机试验 https://news.medxy.ai/ja/acl-reconstruction-outcomes/Medxy AIja2026-10-08T09:33:50-07:00患者教育を併用した監督下運動療法は、ACL再建後の若年成人の転帰を改善する：ランダム化試験 https://news.medxy.ai/vi/supervised-training-outcomes/Medxy AIvi2026-10-08T09:33:26-07:00Tập luyện có giám sát kết hợp giáo dục giúp cải thiện kết cục ở người trẻ sau tái tạo dây chằng chéo trước: một thử nghiệm ngẫu nhiên https://news.medxy.ai/supervised-exercise-therapy-with-education-improves-outcomes-in-young-adults-after-acl-reconstruction-a-randomized-trial/Medxy AIen2026-10-08T09:32:59-07:00Supervised Exercise Therapy with Education Improves Outcomes in Young Adults After ACL Reconstruction: A Randomized Trial https://news.medxy.ai/zh/allogeneic-transplant-outcomes/Medxy AIzh2026-10-08T09:32:17-07:00年轻成人骨髓增生异常综合征异基因造血细胞移植结局：EBMT慢性恶性肿瘤工作组研究启示 https://news.medxy.ai/ja/81730-2/Medxy AIja2026-10-08T09:31:57-07:00若年成人における骨髄異形成症候群への同種造血細胞移植の転帰：EBMT慢性悪性腫瘍ワーキンググループの研究からの示唆 https://news.medxy.ai/vi/hematopoietic-stem-cell-transplant-results/Medxy AIvi2026-10-08T09:31:32-07:00Kết quả ghép tế bào tạo máu dị gen cho hội chứng loạn sản tủy ở người trưởng thành trẻ: Góc nhìn từ Nhóm Công tác Bệnh ác tính mạn tính của EBMT https://news.medxy.ai/outcomes-of-allogeneic-hematopoietic-cell-transplantation-for-myelodysplastic-syndrome-in-young-adults-insights-from-the-ebmt-chronic-malignancies-working-party/Medxy AIen2026-10-08T09:31:11-07:00Outcomes of Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome in Young Adults: Insights from the EBMT Chronic Malignancies Working Party https://news.medxy.ai/zh/81726-2/Medxy AIzh2026-10-08T09:30:31-07:00优化含T细胞造血细胞移植中兔抗胸腺细胞球蛋白（ATG）的暴露水平：基于BMT CTN 1202研究的分析 https://news.medxy.ai/ja/81725-2/Medxy AIja2026-10-08T09:30:09-07:00T細胞除去を行わない造血幹細胞移植におけるウサギATG曝露の最適化：BMT CTN 1202試験の解析 https://news.medxy.ai/vi/optimize-rabbit-atg-exposure/Medxy AIvi2026-10-08T09:29:30-07:00Tối ưu hóa phơi nhiễm rabbit ATG trong ghép tế bào tạo máu còn T đầy đủ: phân tích từ BMT CTN 1202 https://news.medxy.ai/optimizing-rabbit-atg-exposure-in-t-replete-hematopoietic-cell-transplantation-insights-from-bmt-ctn-1202/Medxy AIen2026-10-08T09:29:02-07:00Optimizing Rabbit ATG Exposure in T-Replete Hematopoietic Cell Transplantation: Insights from BMT CTN 1202 https://news.medxy.ai/zh/cd70-acute-leukemia-stem-cells/Medxy AIzh2026-10-08T09:28:17-07:00瞄准不适合强化治疗的急性髓系白血病白血病干细胞：CD70 定向第三药在 ELEVATE 试验中的前景与局限 https://news.medxy.ai/ja/cd70-aml-treatment/Medxy AIja2026-10-08T09:27:54-07:00CD70標的の第三剤で切り込む、治療困難AMLの白血病幹細胞―ELEVATE試験が示す期待と留意点 https://news.medxy.ai/vi/leukemia-stem-cell-targeting/Medxy AIvi2026-10-08T09:27:23-07:00Nhắm đích tế bào gốc bạch cầu trong bệnh bạch cầu tủy cấp không đủ điều kiện điều trị: hy vọng và lưu ý từ thử nghiệm ELEVATE https://news.medxy.ai/targeting-leukemia-stem-cells-in-unfit-acute-myeloid-leukemia-with-a-cd70-directed-third-agent-promise-and-caveats-from-the-elevate-trial/Medxy AIen2026-10-08T09:26:57-07:00Targeting Leukemia Stem Cells in Unfit Acute Myeloid Leukemia with a CD70-Directed Third Agent: Promise and Caveats from the ELEVATE Trial https://news.medxy.ai/zh/cd25-gvhd-prevention/Medxy AIzh2026-10-08T09:25:26-07:00半相合造血干细胞移植后基于CD25的移植物抗宿主病预防：两种预防方案的比较分析 https://news.medxy.ai/ja/cd25-gvhd-prevention-2/Medxy AIja2026-10-08T09:25:06-07:00haplo-HSCT後のCD25ベースGVHD予防：2つの予防レジメンを比較する https://news.medxy.ai/vi/cd25-gvhd-prophylaxis/Medxy AIvi2026-10-08T09:24:42-07:00Dự phòng bệnh ghép chống chủ thể dựa trên CD25 sau ghép tế bào gốc tạo máu đồng loại nửa hòa hợp: phân tích so sánh hai phác đồ dự phòng https://news.medxy.ai/cd25-based-graft-versus-host-disease-prophylaxis-after-haploidentical-hematopoietic-stem-cell-transplantation-comparative-analysis-of-two-prophylactic-regimens/Medxy AIen2026-10-08T09:24:16-07:00CD25-based Graft-versus-Host Disease Prophylaxis after Haploidentical Hematopoietic Stem Cell Transplantation: Comparative Analysis of Two Prophylactic Regimens https://news.medxy.ai/influence-of-clonal-hematopoiesis-and-neutropenia-on-car-t-therapy-outcomes-in-hematologic-malignancies/Medxy AIen2026-10-08T09:23:22-07:00Influence of Clonal Hematopoiesis and Neutropenia on CAR-T Therapy Outcomes in Hematologic Malignancies https://news.medxy.ai/zh/target-aml-stemcells/Medxy AIzh2026-10-08T09:22:38-07:00靶向急性髓系白血病白血病干细胞：通过表观遗传调控克服 PI3K 抑制剂耐药 https://news.medxy.ai/ja/aml-leukemia-targeting/Medxy AIja2026-10-08T09:22:19-07:00AMLの白血病幹細胞を狙い撃ち：エピジェネティック制御でPI3K阻害抵抗性を打破する https://news.medxy.ai/vi/aml-leukemia-treatment/Medxy AIvi2026-10-08T09:21:54-07:00Nhắm vào tế bào gốc bạch cầu trong AML: Vượt qua kháng thuốc với chất ức chế PI3K bằng điều hòa biểu sinh https://news.medxy.ai/targeting-leukemic-stem-cells-in-aml-overcoming-pi3k-inhibitor-resistance-through-epigenetic-modulation/Medxy AIen2026-10-08T09:21:30-07:00Targeting Leukemic Stem Cells in AML: Overcoming PI3K Inhibitor Resistance through Epigenetic Modulation https://news.medxy.ai/zh/ror1-chronic-lymphocytic-leukemia/Medxy AIzh2026-10-08T09:20:49-07:00靶向慢性淋巴细胞白血病中的 ROR1：Zilovertamab 联合 Ibrutinib 在高风险 del(17p) 疾病中的研究启示 https://news.medxy.ai/ja/81703-2/Medxy AIja2026-10-08T09:20:29-07:00慢性リンパ球性白血病におけるROR1を標的とした治療：高リスクdel(17p)症例に対するZilovertamabとイブルチニブの併用療法に関する研究の示唆 https://news.medxy.ai/vi/81702-2/Medxy AIvi2026-10-08T09:20:05-07:00Nhắm đích ROR1 trong bệnh bạch cầu lympho mạn tính: Những hiểu biết từ các nghiên cứu về Zilovertamab kết hợp với Ibrutinib ở bệnh nhân có nguy cơ cao mang đột biến del(17p) https://news.medxy.ai/targeting-ror1-in-chronic-lymphocytic-leukemia-insights-from-the-zilovertamab-and-ibrutinib-combination-in-high-risk-del17p-disease/Medxy AIen2026-10-08T09:19:42-07:00Targeting ROR1 in Chronic Lymphocytic Leukemia: Insights from the Zilovertamab and Ibrutinib Combination in High-Risk del(17p) Disease https://news.medxy.ai/zh/ibrutinib-venetoclax-longterm-results/Medxy AIzh2026-10-08T09:18:46-07:00老年慢性淋巴细胞白血病一线 ibrutinib-venetoclax 的长期疗效与安全性：GLOW 研究 67 个月结果解读 https://news.medxy.ai/ja/ibrutinib-venetoclax-long-term/Medxy AIja2026-10-08T09:18:21-07:00高齢の慢性リンパ性白血病患者における一次治療ibrutinib-venetoclaxの長期有効性と安全性：GLOW試験67か月成績からの示唆 https://news.medxy.ai/vi/ibrutinib-venetoclax-results/Medxy AIvi2026-10-08T09:17:53-07:00Ibrutinib-venetoclax bước một: Hiệu quả và độ an toàn dài hạn ở bệnh bạch cầu lympho mạn tính giai đoạn muộn từ nghiên cứu GLOW 67 tháng https://news.medxy.ai/zh/ctcl-cancer-pathways/Medxy AIzh2026-10-08T09:16:43-07:00解码CTCL：单细胞图谱揭示致癌通路与免疫耐受机制 https://news.medxy.ai/ja/81693-2/Medxy AIja2026-10-08T09:16:25-07:00CTCLの解明：シングルセル・アトラスが明らかにする発がん経路と免疫寛容メカニズム https://news.medxy.ai/vi/ctcl-single-cell-map/Medxy AIvi2026-10-08T09:15:58-07:00Giải mã CTCL: Bản đồ đơn bào hé lộ các con đường sinh ung và cơ chế kháng miễn dịch https://news.medxy.ai/zh/lisocabtagene-followup/Medxy AIzh2026-10-08T09:14:49-07:00lisocabtagene maraleucel 三年随访：复发/难治性滤泡性淋巴瘤中缓解持久且安全性可控 https://news.medxy.ai/ja/relapsed-follicular-lymphoma/Medxy AIja2026-10-08T09:14:27-07:00再発・難治性濾胞性リンパ腫におけるリソカブタゲン マラルユーセル：3年追跡で示された持続的寛解と良好な安全性 https://news.medxy.ai/vi/lisocabtagene-maraleucel-followup/Medxy AIvi2026-10-08T09:14:02-07:00Theo dõi 3 năm lisocabtagene maraleucel: lui bệnh bền vững và an toàn có thể kiểm soát ở u lympho nang tái phát/kháng trị https://news.medxy.ai/zh/tisa-818-ards-study/Medxy AIzh2026-10-08T08:52:32-07:00肺部感染相关ARDS中TISA-818的Ⅱ期研究：基于2023年全球定义的安全性良好与早期疗效信号 https://news.medxy.ai/ja/81683-2/Medxy AIja2026-10-08T08:52:10-07:00肺炎関連ARDSにおけるTISA-818の第II相試験：2023年の世界的な定義に基づく良好な安全性および早期の有効性シグナル https://news.medxy.ai/vi/tisa-ards-safety/Medxy AIvi2026-10-08T08:51:46-07:00TISA-818 trong ARDS do nhiễm trùng phổi: tín hiệu an toàn khả quan và hiệu quả sớm đầy hứa hẹn theo định nghĩa toàn cầu năm 2023 https://news.medxy.ai/tisa-818-in-ards-due-to-pulmonary-infection-promising-safety-and-early-efficacy-signals-with-the-2023-global-definition/Medxy AIen2026-10-08T08:51:23-07:00TISA-818 in ARDS Due to Pulmonary Infection: Promising Safety and Early Efficacy Signals with the 2023 Global Definition https://news.medxy.ai/zh/ceus-biopsy-accuracy/Medxy AIzh2026-10-08T08:50:44-07:00CEUS引导活检显著提升下胸膜肺病变诊断准确性与安全性：大型多中心RCT的启示 https://news.medxy.ai/ja/81678-2/Medxy AIja2026-10-08T08:50:24-07:00CEUSガイド下生検は下胸膜肺病変の診断精度と安全性を著しく向上させる：大規模多施設共同RCTからの示唆 https://news.medxy.ai/vi/81677-2/Medxy AIvi2026-10-08T08:49:58-07:00Sinh thiết dưới hướng dẫn của CEUS giúp cải thiện đáng kể độ chính xác trong chẩn đoán và độ an toàn đối với các tổn thương phổi nằm dưới màng phổi https://news.medxy.ai/enhanced-diagnostic-accuracy-and-safety-of-ceus-guided-biopsy-for-subpleural-lung-lesions-insights-from-a-large-multicenter-rct/Medxy AIen2026-10-08T08:49:31-07:00Enhanced Diagnostic Accuracy and Safety of CEUS-Guided Biopsy for Subpleural Lung Lesions: Insights from a Large Multicenter RCT https://news.medxy.ai/zh/sputum-cell-composition/Medxy AIzh2026-10-08T08:48:51-07:00痰液细胞组成与哮喘、COPD 的医疗服务利用：炎症表型与临床结局的启示 https://news.medxy.ai/ja/81673-2/Medxy AIja2026-10-08T08:48:24-07:00喀痰細胞組成と喘息・COPDにおける医療サービス利用：炎症表現型と臨床転帰からの示唆 https://news.medxy.ai/vi/sputum-leukocytes-copd-asthma/Medxy AIvi2026-10-08T08:47:55-07:00Bạch cầu trong đờm và mức sử dụng dịch vụ y tế ở hen và COPD: gợi ý về kiểu hình viêm và kết cục lâm sàng https://news.medxy.ai/sputum-cellularity-and-health-services-utilization-in-asthma-and-copd-insights-into-inflammatory-phenotypes-and-clinical-outcomes/Medxy AIen2026-10-08T08:47:27-07:00Sputum Cellularity and Health Services Utilization in Asthma and COPD: Insights into Inflammatory Phenotypes and Clinical Outcomes https://news.medxy.ai/zh/polygenic-risk-score/Medxy AIzh2026-10-08T08:29:52-07:00多基因风险评分有助于提升特发性肺纤维化的诊断与预后分层 https://news.medxy.ai/ja/idiopathic-pulmonary-fibrosis-risk/Medxy AIja2026-10-08T08:29:37-07:00特発性肺線維症の診断と予後層別化を高める多遺伝子リスクスコア https://news.medxy.ai/vi/polygenic-risk-ipf/Medxy AIvi2026-10-08T08:29:18-07:00Điểm nguy cơ đa gen hỗ trợ chẩn đoán và phân tầng tiên lượng ở xơ phổi vô căn https://news.medxy.ai/polygenic-risk-score-enhances-diagnosis-and-prognostic-stratification-in-idiopathic-pulmonary-fibrosis/Medxy AIen2026-10-08T08:28:58-07:00Polygenic Risk Score Enhances Diagnosis and Prognostic Stratification in Idiopathic Pulmonary Fibrosis https://news.medxy.ai/zh/immune-pneumonitis-duration/Medxy AIzh2026-10-08T08:28:07-07:00轻度免疫相关肺炎：糖皮质激素疗程应选3周还是6周？随机试验给出答案 https://news.medxy.ai/ja/steroid-treatment-duration/Medxy AIja2026-10-08T08:27:49-07:00軽症の免疫関連肺臓炎に対する最適な副腎皮質ステロイド投与期間を検証する：ランダム化試験からの知見 https://news.medxy.ai/vi/optimal-corticosteroid-duration/Medxy AIvi2026-10-08T08:27:32-07:00Xác định thời gian dùng corticosteroid tối ưu cho viêm phổi liên quan đến miễn dịch mức độ nhẹ: góc nhìn từ một thử nghiệm ngẫu nhiên https://news.medxy.ai/evaluating-optimal-corticosteroid-duration-for-mild-immune-related-pneumonitis-insights-from-a-randomized-trial/Medxy AIen2026-10-08T08:27:14-07:00Evaluating Optimal Corticosteroid Duration for Mild Immune-Related Pneumonitis: Insights from a Randomized Trial https://news.medxy.ai/zh/mycophenolate-vs-azathioprine/Medxy AIzh2026-10-08T08:26:34-07:00纤维化性间质性肺疾病中吗替麦考酚酯与硫唑嘌呤的疗效评估：多中心回顾性研究带来的启示 https://news.medxy.ai/ja/mycophenolate-azathioprine-study/Medxy AIja2026-10-08T08:26:15-07:00線維性間質性肺疾患におけるミコフェノール酸モフェチルとアザチオプリン：多施設後ろ向き研究から見えたもの https://news.medxy.ai/vi/mycophenolate-azathioprine-pulmonary-fibrosis/Medxy AIvi2026-10-08T08:25:55-07:00Mycophenolate và azathioprine trong bệnh phổi kẽ xơ hóa: Những phát hiện từ một nghiên cứu hồi cứu đa trung tâm https://news.medxy.ai/evaluating-mycophenolate-and-azathioprine-in-fibrotic-interstitial-lung-disease-insights-from-a-multicenter-retrospective-study/Medxy AIen2026-10-08T08:25:37-07:00Evaluating Mycophenolate and Azathioprine in Fibrotic Interstitial Lung Disease: Insights from a Multicenter Retrospective Study https://news.medxy.ai/zh/menopause-strabismus/Medxy AIzh2026-10-08T08:24:53-07:00更年期激素治疗与绝经后女性斜视发生及手术结局：有何关联？ https://news.medxy.ai/ja/postmenopausal-hormone-therapy-2/Medxy AIja2026-10-08T08:24:36-07:00閉経後ホルモン療法は斜視発症と手術転帰にどう影響するのか：閉経後女性を対象とした検討 https://news.medxy.ai/vi/menopause-hormone-therapy-impact/Medxy AIvi2026-10-08T08:24:14-07:00Liệu pháp hormone mãn kinh có thể ảnh hưởng thế nào đến lác và kết quả phẫu thuật ở phụ nữ sau mãn kinh https://news.medxy.ai/implications-of-menopausal-hormone-therapy-on-strabismus-incidence-and-surgical-outcomes-in-postmenopausal-women/Medxy AIen2026-10-08T08:23:52-07:00Implications of Menopausal Hormone Therapy on Strabismus Incidence and Surgical Outcomes in Postmenopausal Women https://news.medxy.ai/zh/central-serous-retinopathy/Medxy AIzh2026-10-08T08:23:06-07:00中央浆液性脉络膜视网膜病变中期高荧光斑块：多模态影像揭示其动态演变 https://news.medxy.ai/zh/proton-therapy-uveal-melanoma/Medxy AIzh2026-10-08T08:22:56-07:00眼部质子治疗对葡萄膜黑色素瘤患者角膜基底下神经丛的影响：纵向共聚焦显微镜研究结果 https://news.medxy.ai/ja/central-serous-retinopathy-3/Medxy AIja2026-10-08T08:22:46-07:00中心性漿液性脈絡網膜症における中期高蛍光プラークの解明：マルチモーダル画像から見えた新知見 https://news.medxy.ai/ja/uveal-melanoma-proton-therapy/Medxy AIja2026-10-08T08:22:37-07:00ぶどう膜悪性黒色腫における眼球プロトン療法が角膜上皮下神経叢に及ぼす影響：角膜共焦点顕微鏡による縦断的所見 https://news.medxy.ai/vi/central-serous-retinopathy-2/Medxy AIvi2026-10-08T08:22:26-07:00Giải mã các mảng tăng huỳnh quang ở pha giữa trong bệnh lý hắc võng mạc thanh dịch trung tâm: Góc nhìn từ chẩn đoán hình ảnh đa mô thức https://news.medxy.ai/vi/proton-therapy-effects/Medxy AIvi2026-10-08T08:22:15-07:00Ảnh hưởng của liệu pháp proton nhãn cầu lên đám rối thần kinh dưới nền giác mạc ở uveal melanoma: Phát hiện theo dõi bằng kính hiển vi đồng tiêu https://news.medxy.ai/unraveling-mid-phase-hyperfluorescent-plaques-in-central-serous-chorioretinopathy-insights-from-multimodal-imaging/Medxy AIen2026-10-08T08:22:04-07:00Unraveling Mid-phase Hyperfluorescent Plaques in Central Serous Chorioretinopathy: Insights from Multimodal Imaging https://news.medxy.ai/impact-of-ocular-proton-therapy-on-corneal-subbasal-nerve-plexus-in-uveal-melanoma-longitudinal-confocal-microscopy-findings/Medxy AIen2026-10-08T08:21:54-07:00Impact of Ocular Proton Therapy on Corneal Subbasal Nerve Plexus in Uveal Melanoma: Longitudinal Confocal Microscopy Findings https://news.medxy.ai/zh/temporal-meningioma-prediction/Medxy AIzh2026-10-08T08:21:09-07:00岩斜区与颞骨脑膜瘤手术结局预测：一种新型描述性分层框架的价值 https://news.medxy.ai/ja/petroclival-meningioma-prediction/Medxy AIja2026-10-08T08:20:53-07:00Petroclival・Temporal Bone Meningiomaの手術転帰予測精度を高める新規記述的フレームワーク https://news.medxy.ai/vi/improved-meningioma-surgery-prediction/Medxy AIvi2026-10-08T08:20:34-07:00Khung mô tả mới giúp tăng độ chính xác dự đoán kết cục phẫu thuật u màng não vùng xương đá–dốc nền và xương thái dương https://news.medxy.ai/a-novel-descriptive-framework-enhances-predictive-accuracy-for-surgical-outcomes-in-petroclival-and-temporal-bone-meningiomas/Medxy AIen2026-10-08T08:20:16-07:00A Novel Descriptive Framework Enhances Predictive Accuracy for Surgical Outcomes in Petroclival and Temporal Bone Meningiomas https://news.medxy.ai/zh/bmi-effects-airway-reconstruction/Medxy AIzh2026-10-08T08:19:31-07:00BMI升高会影响开放性气道重建吗？术后结局解析 https://news.medxy.ai/ja/bmi-airway-reconstruction/Medxy AIja2026-10-08T08:19:14-07:00BMI高値でも開放的気道再建の予後は悪化しない：術後転帰への影響を検証 https://news.medxy.ai/vi/high-bmi-airway-reconstruction/Medxy AIvi2026-10-08T08:18:54-07:00BMI cao và tái tạo đường thở mở: Tách bạch tác động lên kết cục sau mổ https://news.medxy.ai/elevated-bmi-and-open-airway-reconstruction-disentangling-the-impact-on-postoperative-outcomes/Medxy AIen2026-10-08T08:18:32-07:00Elevated BMI and Open Airway Reconstruction: Disentangling the Impact on Postoperative Outcomes https://news.medxy.ai/zh/tranexamic-acid-safety/Medxy AIzh2026-10-08T08:17:53-07:00头颈部游离皮瓣重建中氨甲环酸的安全性与疗效：一项回顾性队列研究 https://news.medxy.ai/ja/81628-2/Medxy AIja2026-10-08T08:17:37-07:00頭頸部における遊離皮弁再建術でのトラネキサム酸の安全性と有効性の評価：後方視的コホート研究からの検討 https://news.medxy.ai/long-term-efficacy-and-safety-of-first-line-ibrutinib-venetoclax-in-older-patients-with-chronic-lymphocytic-leukemia-insights-from-the-67-month-glow-study/Medxy AIen2026-10-08T08:17:31-07:00Long-Term Efficacy and Safety of First-Line Ibrutinib-Venetoclax in Older Patients with Chronic Lymphocytic Leukemia: Insights from the 67-Month GLOW Study https://news.medxy.ai/vi/tranexamic-acid-safety-3/Medxy AIvi2026-10-08T08:17:17-07:00Đánh giá độ an toàn và hiệu quả của acid tranexamic trong tái tạo vạt tự do vùng đầu và cổ: Góc nhìn từ một nghiên cứu đoàn hệ hồi cứu https://news.medxy.ai/tranexamic-acid-safety-2/Medxy AIen2026-10-08T08:16:56-07:00Evaluating Tranexamic Acid’s Safety and Efficacy in Head and Neck Free Flap Reconstruction: Insights from a Retrospective Cohort Study https://news.medxy.ai/zh/bedside-stomach-ultrasound/Medxy AIzh2026-10-08T08:16:16-07:00护士实施胃部床旁超声用于术后胃内容物评估：可行性与临床应用价值 https://news.medxy.ai/ja/g-pocus-stomach-evaluation/Medxy AIja2026-10-08T08:15:58-07:00術後胃内容評価における胃POCUS（G-POCUS）の実施可能性と臨床的有用性 https://news.medxy.ai/vi/bedside-stomach-ultrasound-2/Medxy AIvi2026-10-08T08:15:38-07:00Siêu âm tại giường dạ dày (G-POCUS) trong đánh giá hậu phẫu: tính khả thi và giá trị lâm sàng https://news.medxy.ai/decoding-ctcl-a-single-cell-atlas-reveals-oncogenic-pathways-and-immune-resistance-mechanisms/Medxy AIen2026-10-08T08:15:35-07:00Decoding CTCL: A Single-Cell Atlas Reveals Oncogenic Pathways and Immune Resistance Mechanisms https://news.medxy.ai/feasibility-and-clinical-utility-of-gastric-point-of-care-ultrasound-g-pocus-for-postoperative-gastric-content-assessment/Medxy AIen2026-10-08T08:15:14-07:00Feasibility and Clinical Utility of Gastric Point-of-Care Ultrasound (G-POCUS) for Postoperative Gastric Content Assessment https://news.medxy.ai/zh/breast-cancer-treatment/Medxy AIzh2026-10-08T08:14:35-07:00乳腺癌年轻女性的外科治疗模式与结局如何演变：基于十年国家数据库的洞见 https://news.medxy.ai/ja/young-female-breast-cancer-surgery/Medxy AIja2026-10-08T08:14:17-07:00若年乳癌女性における外科治療の変化と転帰：全国データ10年分から見えたこと https://news.medxy.ai/vi/breast-cancer-trends-2/Medxy AIvi2026-10-08T08:13:58-07:00Xu hướng phẫu thuật và kết cục ở phụ nữ trẻ mắc ung thư vú: Góc nhìn từ dữ liệu quốc gia trong 10 năm https://news.medxy.ai/evolving-surgical-patterns-and-outcomes-in-young-women-with-breast-cancer-insights-from-a-decade-of-national-data/Medxy AIen2026-10-08T08:13:38-07:00Evolving Surgical Patterns and Outcomes in Young Women with Breast Cancer: Insights from a Decade of National Data